Navigation Links
Grifols implementa il suo primo sistema a carosello per la gestione automatizzata dell'inventario dei farmaci sperimentali presso la Emory University
Date:7/18/2013

LOS ANGELES, 18 luglio 2013 /PRNewswire/ -- Grifols, società mondiale del settore sanitario con sede a Barcellona, Spagna, che vanta oltre 15 anni di innovazione ed esperienza nel settore delle soluzioni automatizzate per la conservazione e la distribuzione dei farmaci nelle farmacie ospedaliere europee, ha ora implementato negli Stati Uniti il suo primo nastro trasportatore per la gestione automatizzata dell'inventario.

L'attività della Divisione Ospedaliera di Grifols è focalizzata su soluzioni tecnologiche per il mercato della farmacia ospedaliera. Grifols ha implementato presso l'Emory University Investigational Drug Service un nastro trasportatore SencorpWhite per la gestione automatizzata dell'inventario; il sistema è gestito dal software Genesis Investigational Drug Service (IDS). Il software Genesis IDS consente di conservare i farmaci, controllare l'inventario e tracciare le transazioni in modo efficiente. 

Susan Rogers, RPh, Emory University Investigational Drug Service, ha così commentato l'impatto  della macchina: "Il sistema a carosello ha consentito notevoli risparmi in termini di spazio e di tempo.  L'inventario è organizzato meglio, e con il software Genesis IDS è possibile conoscere l'esatta posizione dei farmaci. Ciò consente di risparmiare tempo durante il reintegro delle scorte, la distribuzione dei farmaci e gli inventari ciclici, ottenendo maggiore efficienza, qualità e, in ultima analisi, più sicurezza per il paziente."

Il sistema è inoltre interfacciato con il software Vestigo® Investigational Drug Service (IDS) utilizzato dall'Università Emory. Vestigo è la soluzione leader di mercato che permette di migliorare l'accuratezza, l'efficienza e la sicurezza dell'industria IDS con strumenti automatici per la gestione dei protocolli e dell'inventario elettronico, la distribuzione e
'/>"/>

SOURCE Grifols
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Grifols Initiates Safety Study of Inhaled Alpha1-Proteinase Inhibitor (Human) Following Orphan Drug Designation for Cystic Fibrosis
2. Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency
3. Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt
4. Grifols Implements Its First Automated Inventory Management Carousel System for Investigational Pharmacies at Emory University
5. CalHIPSO Enrolls Over 7,700 Providers in EHR Implementation Program, Hits Other Key Milestones After First Two Years
6. Regional Medical Center at Memphis Completes Rapid Six-Month Implementation of Comprehensive Perioperative and Anesthesia Solution from Surgical Information Systems
7. Outpatient Imaging Affiliates Completes Phase I Of An Interoperability And Workflow Implementation With Compressus
8. Free Download -- QbD Implementation for Pharma Companies
9. Pharmaceutical Companies On Defense As Post-ACA Implementation Continues
10. Biotech industry has "implementation gap" around demonstrating the value of products under development
11. EarlySense System Implementation Shown to Reduce Falls, Decrease Transfers to Hospitals and Increase the Quality of Care for Elderly in Multi-Center Nursing Home Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: Global Markets ... -- Focus on End Users ... A drug delivery system is ...
(Date:1/14/2014)... 2014  Luminex Corporation (Nasdaq: LMNX ) today announced ... of 2013 on Monday, February 3, 2014. A press release ... of trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... operating highlights and financial results for the fourth quarter and ...
(Date:1/14/2014)... , Jan. 14, 2014 Animal Emergency Critical Care, a ... Leesburg, Virginia is the first in ... chamber. Dr. Susan M. Barnes , Medical ... Barnes and husband, Dr. Cole Taylor , are avid scuba ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2
... PharmAthene, Inc. (NYSE Amex: PIP ) a ... threats, announced today that it will be hosting a ... at 4:30 p.m. E.T., to review the status of ... the United States is 866-788-0540. The dial-in number ...
... Results from two prospective, double-blind placebo controlled multi-center studies ... European efficacy and safety data in patients with focal ... at the American Academy of Neurology,s (AAN) 61st annual ... Merz Pharmaceuticals, which plans to file a Biologic License ...
Cached Medicine Technology:PharmAthene to Host a Conference Call and Webcast on Wednesday, April 29th at 4:30 PM to Provide an Update on the SparVax(TM) rPA Anthrax Vaccine Program 2Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients 2Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients 3Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients 4Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients 5
(Date:7/10/2014)... of the top public health concerns in the United ... as obese as of 2012. As health problems such ... to Twitter to discuss the problem. , A new ... at the Brown School at Washington University in St. ... tweets to track Twitter conversations about the issue of ...
(Date:7/10/2014)... EAST LANSING, Mich. For those students looking to ... answer may not be spending more time in a ... New Michigan State University research shows that students who ... on MSU,s campus during their freshman and sophomore years ... The research also indicated that students with memberships stayed ...
(Date:7/10/2014)... at the University of Huddersfield could help to improve ... food products such as butter, mayonnaise, yoghurt and ... an international profile for her work. , Katerina gained ... the University and now she has embarked on research ... Vassilis Kontogiorgos, she is investigating the potential of carbohydrates ...
(Date:7/10/2014)... A neuroscientist at Rutgers University-Newark says the human brain ... a finding that could provide a better understanding ... conditions that afflict an estimated 13.6 million Americans. , ... , Michael Cole, an assistant professor at the Center ... brain architecture of a person at rest is basically ...
(Date:7/10/2014)... the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan ... patients a new therapeutic combination to combat resistant sarcomas. ... treatment could stabilize the growth of these tumors have ... of Cancer ., Sarcomas , Sarcomas are a ... several subtypes. It can affect from children to older ...
Breaking Medicine News(10 mins):Health News:Study looks at how Twitter can be used to address specific health issues 2Health News:Want a higher GPA in college? Join a gym 2Health News:World interest in research work on the benefits of the Okra plant 2Health News:Working to loosen the grip of severe mental illness 2Health News:New therapeutic combination to slow resistant sarcomas 2
... panic. The following summarizes a new list of suggestions ... non-partisan National Center for Policy Analysis. Authored by NCPA ... full article is not sponsored by any commercial entity, ... Link to full article: http://www.ncpa.org/pdfs/Seven_Ways_Job_3-16-09-FINAL-A.pdf Here ...
... ... Newark, DE (PRWEB) March 17, 2009 ... ) have demonstrated that single embryos cultured under proper conditions ... successfully in women under age 35. In national results ...
... 17 eCardio Diagnostics ( www.ecardio.com ) announced ... Medicine initiative to provide a tailored offering to ... time an arrhythmia monitoring company has addressed the ... medical centers. "At eCardio, we work closely ...
... Leading HIFU device in Mexico for Minimally Invasive ... draws attention from elite urologistsCHARLOTTE, N.C., March 16 ... the Mexican and international entities of USHIFU, a ... of high intensity focused ultrasound (HIFU) technologies, will ...
... Boston, Mass. - Many households harbor a threat to ... tables and tables with glass panels. A review by ... publisher of Consumer Reports, finds that glass-table injuries aren,t ... could have been avoided had tempered glass been used. ...
... Less Than $1 MillionGross Margin Increases to 57.1%Programs ... & 2010First Quarter Sales Off to Strong StartMONROVIA, ... STAA ), a leading developer, manufacturer ... reported financial results for the fourth quarter and ...
Cached Medicine News:Health News:7 Ways to Keep Health Coverage If You Lose Your Job 2Health News:Most IVF Patients Under 35 Should Have Single Embryo Transfer, According to Latest SART Data 2Health News:Most IVF Patients Under 35 Should Have Single Embryo Transfer, According to Latest SART Data 3Health News:eCardio Diagnostics Launches Academic Medicine Initiative 2Health News:High Intensity Focused Ultrasound Physician Training Seminar in Mexico City 2Health News:Glass tables: An overlooked safety threat 2Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 2Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 3Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 4Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 5Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 6Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 7Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 8Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 9Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 10Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 11Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 12Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 13Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 14Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 15Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 16Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 17Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 18Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 19Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 20Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 21Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 22Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 23Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 24Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 25
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: